Indefinite Delivery Contract SPE2D222D0147
Award Date
9/14/22
Last Date to Order
9/13/27
Federal Agency
Medical Supply Chain
Awardee
Mylan Pharmaceuticals Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This Indefinite Delivery Contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) National Acquisition Center to Mylan Pharmaceuticals Inc., a for-profit manufacturer of pharmaceutical goods. The single-award IDC, with a ceiling value of $8,346,790.65, is for the supply of clozapine tablets to the VA, Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS) over a 5-year period from March 2023 to March 2026. The contract was competitively...
The federal contract IDV award to Mylan Pharmaceuticals Inc. is a single-award Indefinite Delivery Contract (IDC) issued by the Department of Veterans Affairs (VA) National Acquisition Center. The contract, valued at up to $9,549,893.15 over its 5-year period of performance, enables Mylan to supply clozapine tablets to the VA, Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). This contract is an extension of Mylan's ongoing role as a prime vendor of specialty...
This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $499,999,999 single-award IDC, under the SPE2DB program, runs through December 31, 2025 and allows DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products to support the recurring medical supply needs of military health facilities worldwide. The IDC covers a vast array...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The single-award IDC, valued at up to $499,999,999, covers a comprehensive range of pharmaceutical products to fulfill the recurring medical supply needs of military health facilities worldwide under the SPE2DB program. The contract includes a vast array of pharmaceutical items, from common medications to specialized...
This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $499,999,999 single-award IDC, valid through November 30, 2026, covers a comprehensive range of pharmaceutical products and medical supplies to fulfill the recurring medical needs of military health facilities worldwide under the SPE2DB program. The contract scope includes branded...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA), a defense agency, to Specgx LLC, doing business as Mallinckrodt Pharmaceuticals, a foreign-owned for-profit pharmaceutical manufacturer. The contract has a total ceiling value of $29,250,715.90 and an ultimate completion date of February 12, 2030. The IDC covers the supply of various controlled substance pharmaceutical products, including methadone cherry liquid, oxycodone placebo tablets,...
The indefinite delivery contract (IDC) SPE2DB25D3022 was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The single-award IDC, valued at $999,999,999, covers the period from October 2024 through December 2026. The contract provides for the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes specialty...
This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) under its Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The single-award IDC, valued at up to $499,999,999, allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. The contract encompasses the...
This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The single-award IDC, valued up to $499,999,999, covers the period from October 2, 2024 through December 31, 2025. Under this IDC, DMS Pharmaceutical Group will provide a comprehensive range of pharmaceutical products and medical supplies to fulfill the recurring medical needs of military health facilities worldwide....
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The single-award IDC, valued up to $499,999,999, covers a comprehensive range of pharmaceutical products and medical supplies to fulfill the recurring needs of military health facilities worldwide under the SPE2DB program. The contract includes firm fixed-price delivery orders for common medications like...